Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 11:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1585–1608 of 7,897 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non intervention study Clear all

Conditions: Essential Tremor
Interventions: Cala ONE device; Device
Lead sponsor: Cala Health, Inc.; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Oakland, California • Denver, Colorado • Kansas City, Kansas + 1 more

Conditions: Non-Small Cell Lung Cancer
Interventions: Durvalumab, Placebo, Carboplatin, Cisplatin, Pemetrexed, Paclitaxel, Gemcitabine, Surgery; Drug · Other · Procedure
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 120 Years
Enrollment: 825 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 31
States / cities: Phoenix, Arizona • Duarte, California • Orange, California + 25 more

Conditions: Post-Traumatic Stress Disorder
Interventions: Continuous theta burst stimulation (cTBS), Sham continuous theta burst stimulation (cTBS); Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: TARA v3.1, only non-pharmacological self-management support, TARA v3.2, both non-pharmacological and pharmacological self-management support; Device
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Gastonia, North Carolina • Charleston, South Carolina

Conditions: Obsessive Compulsive Disorder
Interventions: sertraline, psychotherapy; Drug · Behavioral
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 6 Years to 16 Years
Enrollment: 941 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 44
States / cities: Dothan, Alabama • Imperial, California • Los Angeles, California + 39 more

Conditions: Cataract
Interventions: Levofloxacin Ocular Implant; Drug
Lead sponsor: PolyActiva Pty Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: St Louis, Missouri • Ladson, South Carolina

Conditions: Human Immunodeficiency Virus
Interventions: Maraviroc along with an optimized background antiretroviral drug regimen, Optimized background antiretroviral drug regimen without maraviroc; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 145
States / cities: Hobson City, Alabama • Huntsville, Alabama • Bakersfield, California + 87 more

Conditions: Multiple Myeloma, Myeloma
Interventions: FT576 (Allogenic CAR NK cells with BCMA expression), Cyclophosphamide, Fludarabine, Daratumumab, Bendamustine; Drug
Lead sponsor: Fate Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 14
States / cities: Birmingham, Alabama • Duarte, California • Denver, Colorado + 11 more

Conditions: Lung Cancer
Interventions: Screening; Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 82 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: PTSD
Interventions: Attention Control Training, Comparison Task; Behavioral
Lead sponsor: Creighton University; Other
Eligibility: 7 Years to 15 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Covid19, SARS-CoV Infection, ARDS, ARDS, Human
Interventions: Instilled T3, Placebo Therapy; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Screening Colonoscopy
Interventions: Peer PN, Pro PN; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years and older
Enrollment: 800 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Obstructive Sleep Apnea
Interventions: Tonsillectomy; Procedure
Lead sponsor: University of Southern California; Other
Eligibility: 17 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Generalized Anxiety Disorder, Social Phobia, Separation Anxiety Disorder
Interventions: Computerized Cognitive Behavioral Therapy, Treatment as usual; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 7 Years to 13 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 4
States / cities: Clearwater, Florida • Fort Lauderdale, Florida • Pensacola, Florida + 1 more

Conditions: End-Stage Renal Disease
Interventions: Nudge for PHPC Referral; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 285 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stress, Job Stress
Interventions: digital support: text messages; Behavioral
Lead sponsor: Duquesne University; Other
Eligibility: 19 Years to 37 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 4
States / cities: Brawley, California • El Centro, California • San Diego, California + 1 more

Conditions: Surgical Site Infection, Superficial Surgical Site Infection, Deep Surgical Site Infection, Organ/Space Surgical Site Infection
Interventions: Hair clipping; Procedure
Lead sponsor: Gundersen Lutheran Medical Foundation; Other
Eligibility: 18 Years and older
Enrollment: 1,678 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: La Crosse, Wisconsin

Conditions: Bacterial, Viral and Other Infectious Agents
Interventions: Removal of triclosan-containing cleaning products from household.; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 361 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Stanford, California

Conditions: Smoking Cessation
Interventions: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention, E-Referral to the Tobacco Quitline; Behavioral
Lead sponsor: Georgetown University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 1,188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Acquired Hemophilia A
Interventions: OBIZUR; Biological
Lead sponsor: Baxalta now part of Shire; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 6
States / cities: Gainesville, Florida • Detroit, Michigan • Durham, North Carolina + 2 more

Conditions: Elevated Blood Pressure, Hypertension
Interventions: Dietitian-Assisted DASH groceries, Self-directed shopping; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hearing Loss, Conductive, Hearing Loss, Mixed, Hearing Loss, Unilateral
Interventions: SoundArc; Device
Lead sponsor: Cochlear; Industry
Eligibility: 5 Years to 12 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 3
States / cities: Chandler, Arizona • San Diego, California • Fort Worth, Texas

Conditions: Resectable Intrahepatic Cholangiocarcinoma
Interventions: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Futibatinib, Gemcitabine, Magnetic Resonance Imaging; Procedure · Drug · Biological
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Preoperative Anxiety
Interventions: Virtual reality; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 5 Years to 12 Years
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Search by objective public record fields.

A Pilot Study of the Cala ONE Device for Essential Tremor

A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

Disrupting Fear-based Memory Consolidation

Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD

Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)

Levofloxacin Ocular Implant for Ocular Surgery

Prospective Observational Epidemiologic Study of Maraviroc's Safety

FT576 in Subjects With Multiple Myeloma

Pilot Study of High Risk Lung Cancer Screening

Attention Control Training for PTSD in Children

Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome

Peer Patient Navigation for Colon Cancer Screening

Tonsillectomy in Adults With Tonsillar Hypertrophy and Obstructive Sleep Apnea

Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers

Study of Home-Embedded Palliative Care for Hemodialysis-Dependent End-Stage Renal Disease

Digital Support Intervention on Newly Licensed Nurses

Clipping Versus No Hair Removal and the Risk of Surgical Site Infections

Stanford's Outcomes Research in Kids

Tobacco Education and Lung Health Study (TEAL)

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice

Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension

Evaluation of the Baha SoundArc in Pediatric Patients

Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial

Comparing Virtual Reality (VR) to Non-VR for Decreasing Preoperative/Procedural Anxiety